ExeVir Bio
Description: ExeVir Bio develops llama-derived antibody therapies for broad coronavirus protection, using rapid-response VHH tech for global viral threats.
Country: Belgium
Based in: Zwijnaarde
Founded: 2020
Funding Stage: Series A/B
Tags: ['Biotechnology', 'Health Care', 'Life Science', 'Therapeutics']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.